Celyad

is a Belgium-based biotechnology company that researches and develops T-cell therapeutics for the treatment of cancer...
Read more
Celyad CEO: Matt Kane

CEO

Matt Kane

CEO Approval Rating

- -/100

2007

PublicIndependent CompanyNASDAQCYAD

2836 NAICS listing
Annual Revenue
$ < 1M
Employees
12
Funding
$265.1M

Celyad Competitors

1Promethera
2iTeos
3Epics Therapeutics
4bluebird bio
5Cellectis
6Corvidia
7Juno Therapeutics
8Novartis
9GSK
10Amgen
See 21+ competitors

Trending Companies